In conclusion, our current findings demonstrated a novel finding that ATRA may induce synergistic and beneficial effects in TGF-β2-treated 2D- and 3D-cultured HTM cells, providing fundamental evidence of the therapeutic potential of modulating RA-related nuclear receptor actions within glaucoma. This evidence concerns the gene TGFB2 and glaucoma.